![Robert Coffin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Coffin
No open positions remaining
Profile
Robert Coffin was the founder of BioVex, Inc. (1999, Chief Technology Officer), BioVex Group, Inc. (1999, Director & Chief Technology Officer), Replimune Group, Inc. (2015, Director & Chief Scientist), and Replimune Ltd. (2015, Chief Executive Officer).
Former job at BioVex Ltd. (1999-2011, Director & Chief Technology Officer) and Amgen, Inc. (2011-2013, Vice President-Global Development).
Education includes a doctorate from Imperial College London (1991).
Former positions of Robert Coffin
| Companies | Position | End |
|---|---|---|
| REPLIMUNE GROUP, INC. | Chief Executive Officer | 2020-01-08 |
Replimune Ltd.
 Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Research and develops cancer therapeutics | Chief Executive Officer | 2017-07-09 |
| AMGEN INC. | Corporate Officer/Principal | 2012-12-31 |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Chief Tech/Sci/R&D Officer | 2011-03-03 |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Founder | 2010-12-31 |
Training of Robert Coffin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Commercial Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Replimune Ltd.
Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Research and develops cancer therapeutics | Commercial Services |
- Stock Market
- Insiders
- Robert Coffin
Choose MarketScreener 
